ArticleScientific reports2026
Rescue of ICSI failure in non-obstructive azoospermia by switching from cryopreserved to fresh testicular sperm: a paired clinical analysis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Non-obstructive azoospermia (NOA) is a severe form of male infertility. Although cryopreserved testicular sperm are widely used for intracytoplasmic sperm injection (ICSI), a subset of patients experience poor outcomes with a specific frozen-thawed sample. This study aimed to evaluate whether obtaining fresh testicular sperm via repeat mTESE could serve as a rescue strategy for NOA patients with prior poor or failed ICSI outcomes using cryopreserved sperm. This retrospective paired clinical study included 20 men with NOA who underwent microdissection testicular sperm extraction (mTESE) and two ICSI cycles between December 2019 and February 2024 at a tertiary reproductive center. Each patient first underwent ICSI using cryopreserved-thawed testicular sperm, followed by a second ICSI cycle using fresh testicular sperm. Fertilization rate, 2PN rate, number of available embryos, clinical pregnancy rate, and live birth rate were compared between paired cycles using appropriate statistical tests.As a rescue-focused paired design, this cohort was intentionally enriched for patients with poor first-cycle outcomes and therefore does not represent an unselected NOA population. Switching to fresh testicular sperm significantly improved fertilization rate (86.7% vs. 62.7%, P = 0.0045), number of available embryos (3.50 ± 2.24 vs. 1.05 ± 0.60, P = 0.0005), clinical pregnancy rate (55.0% vs. 15.0%, P = 0.021), and live birth rate (45.0% vs. 5.0%, P = 0.008). The 2PN rate was higher but not statistically significant (79.5% vs. 68.5%, P = 0.094). Progressive motility sperm were more frequent in fresh samples (75% vs. 20%, P = 0.0003). No adverse events occurred. In NOA patients with prior poor or failed ICSI outcomes using cryopreserved testicular sperm, repeating mTESE to obtain fresh sperm was associated with significantly improved fertilization and pregnancy outcomes. These findings support fresh testicular sperm as an individualized rescue option rather than evidence of universal superiority over cryopreserved sperm in the general NOA population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.